Abrdn Healthcare Investors (NYSE:HQH - Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 64,800 shares, a growth of 82.0% from the April 30th total of 35,600 shares. Based on an average trading volume of 211,800 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.1% of the shares of the stock are short sold.
Abrdn Healthcare Investors Stock Performance
HQH traded up $0.15 during trading on Monday, reaching $15.37. The stock had a trading volume of 113,666 shares, compared to its average volume of 216,480. Abrdn Healthcare Investors has a 1-year low of $13.77 and a 1-year high of $19.79. The stock has a 50 day moving average of $15.49 and a two-hundred day moving average of $16.57.
Abrdn Healthcare Investors Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Thursday, May 22nd will be given a $0.54 dividend. The ex-dividend date of this dividend is Thursday, May 22nd. This is a boost from Abrdn Healthcare Investors's previous quarterly dividend of $0.50. This represents a $2.16 annualized dividend and a yield of 14.06%.
Institutional Investors Weigh In On Abrdn Healthcare Investors
A number of institutional investors and hedge funds have recently bought and sold shares of HQH. Wolverine Asset Management LLC acquired a new position in shares of Abrdn Healthcare Investors in the 4th quarter valued at $2,196,000. Baird Financial Group Inc. lifted its stake in Abrdn Healthcare Investors by 45.2% during the fourth quarter. Baird Financial Group Inc. now owns 97,843 shares of the financial services provider's stock valued at $1,570,000 after buying an additional 30,451 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in shares of Abrdn Healthcare Investors by 10.4% in the fourth quarter. Ameriprise Financial Inc. now owns 287,607 shares of the financial services provider's stock worth $4,616,000 after buying an additional 27,043 shares during the period. Raymond James Financial Inc. purchased a new position in shares of Abrdn Healthcare Investors in the fourth quarter worth approximately $15,049,000. Finally, Steward Partners Investment Advisory LLC increased its position in shares of Abrdn Healthcare Investors by 20.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 22,358 shares of the financial services provider's stock worth $359,000 after acquiring an additional 3,737 shares in the last quarter. 32.60% of the stock is owned by institutional investors and hedge funds.
Abrdn Healthcare Investors Company Profile
(
Get Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Read More
Before you consider Abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abrdn Healthcare Investors wasn't on the list.
While Abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.